查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765231

全球智慧藥丸市場

Smart Pills
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球智慧藥丸市場規模將達到 11 億美元

全球智慧藥丸市場規模預計在2024年為5.505億美元，預計到2030年將達到11億美元，在2024-2030年的分析期內，複合年成長率為11.6%。食道是本報告分析的細分市場之一，預計其複合年成長率為12.1%，到分析期結束時將達到2.384億美元。小腸細分市場在分析期間內的複合年成長率預計為12.5%。

美國市場規模估計為 1.515 億美元，中國市場預計複合年成長率為 10.8%

美國智慧藥丸市場規模預計在2024年達到1.515億美元。作為世界第二大經濟體，中國市場規模預計在2030年達到1.63億美元，在2024-2030年的分析期間內，複合年成長率為10.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為10.2%和9.6%。在歐洲，預計德國市場的複合年成長率約為8.4%。

全球智慧藥丸市場－主要趨勢與促進因素摘要

什麼是智慧藥丸？它們將如何徹底改變醫療保健？

智慧藥丸配備感測器、攝影機和通訊模組，能夠提供服藥依從性、生理參數和胃腸道狀況的即時數據，從而徹底改變醫療保健產業。這些可吞服的設備擴大用於診斷、監測和藥物輸送，為傳統診斷和治療方法提供了非侵入式的替代方案。智慧藥丸允許醫療保健提供者遠端監測患者的健康狀況，並根據數據做出治療調整決策，從而實現個人化醫療。它們還能提高患者的服藥順從性，尤其是在糖尿病、心血管疾病和精神疾病等慢性疾病領域。

哪些細分市場引領智慧藥丸市場？

這些器官包括食道、小腸、大腸和胃。感測器智慧藥丸因其在監測和診斷領域的廣泛應用而處於領先地位。應用領域分為膠囊內視鏡檢查、病患監測和藥物輸送，其中膠囊內視鏡檢查因其在胃腸道診斷中的應用日益廣泛而佔據市場主導地位。終端使用者包括醫院和診所、研究機構和居家醫療，但由於智慧藥丸在高級診斷和個人化治療方案中的應用日益廣泛，醫院和診所佔據了最大的市場佔有率。

哪些趨勢將塑造智慧藥丸的未來？

智慧藥丸市場受多種趨勢影響，包括感測器技術、微型化和數據分析的進步。人工智慧和機器學習的融合使智慧藥丸能夠提供更精準、更具預測性的健康洞察，從而提升診斷和治療的可能性。人們對數位健康和​​遠端醫療的日益關注，推動了對具有遠端監控和即時數據傳輸功能的智慧藥丸的需求。此外，個人化醫療的趨勢也推動了具有靶向藥物傳輸和反饋機制的智慧藥丸的發展。製藥公司與科技公司之間的合作正在進一步加速智慧藥丸技術的創新。

哪些因素推動了智慧藥丸市場的成長？

智慧藥丸市場的成長受到多種因素的推動，例如對遠端患者監護和數位健康解決方案的需求不斷成長、感測器和微型化技術的進步、對個人化醫療和標靶藥物輸送的日益關注。此外，老年人口的成長和慢性病的流行、遠端醫療和數位治療方法的擴展，以及製藥公司和科技公司之間日益增多的合作，也促進了市場的成長。此外，經濟高效且方便用戶使用的智慧藥丸解決方案的開發、支持性法規結構的完善以及對數位健康技術不斷成長的投資，都在推動市場向前發展。

部分

應用（膠囊內視鏡、藥物傳遞、病患監測）；最終用途（醫院、診斷中心、研究實驗室）；目標區域（食道、小腸、大腸、胃）

受訪公司範例

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology（Group）Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自全球領域專家的精選內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP14835

Global Smart Pills Market to Reach US$1.1 Billion by 2030

The global market for Smart Pills estimated at US$550.5 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 11.6% over the analysis period 2024-2030. Esophagus, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$238.4 Million by the end of the analysis period. Growth in the Small Intestine segment is estimated at 12.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$151.5 Million While China is Forecast to Grow at 10.8% CAGR

The Smart Pills market in the U.S. is estimated at US$151.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$163.0 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.2% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Smart Pills Market - Key Trends and Drivers Summarized

What Are Smart Pills and How Are They Revolutionizing Healthcare?

Smart pills, equipped with sensors, cameras, and communication modules, are revolutionizing healthcare by providing real-time data on medication adherence, physiological parameters, and gastrointestinal conditions. These ingestible devices are increasingly being used for diagnostic, monitoring, and drug delivery purposes, offering a non-invasive alternative to traditional diagnostic and therapeutic methods. Smart pills are enabling personalized medicine by allowing healthcare providers to monitor patient health remotely and make data-driven decisions for treatment adjustments. They are also improving patient compliance with medication regimens, particularly for chronic diseases such as diabetes, cardiovascular disorders, and mental health conditions.

Which Segments Are Leading in the Smart Pills Market?

Target Areas include esophagus, small intestine, large intestine, and stomach. Sensor-enabled smart pills lead due to their extensive use in monitoring and diagnostics. Applications are categorized into capsule endoscopy, patient monitoring, and drug delivery, with capsule endoscopy dominating the market owing to its growing adoption in gastrointestinal diagnostics. End-users range from hospitals and clinics to research institutions and home care settings, with hospitals and clinics holding the largest market share due to the increasing use of smart pills in advanced diagnostics and personalized treatment plans.

What Trends Are Shaping the Future of Smart Pills?

The smart pills market is being shaped by several trends, including advancements in sensor technologies, miniaturization, and data analytics. The integration of AI and machine learning is enabling smart pills to provide more accurate and predictive health insights, enhancing their diagnostic and therapeutic potential. The rising focus on digital health and telemedicine is driving the demand for smart pills that offer remote monitoring and real-time data transmission. Additionally, the trend towards personalized medicine is spurring the development of smart pills with targeted drug delivery and feedback mechanisms. Collaborations between pharmaceutical companies and tech firms are further accelerating innovation in smart pill technologies.

What Factors Are Driving Growth in the Smart Pills Market?

The growth in the smart pills market is driven by several factors, including the increasing demand for remote patient monitoring and digital health solutions, advancements in sensor and miniaturization technologies, and the rising focus on personalized medicine and targeted drug delivery. The growth in the geriatric population and the prevalence of chronic diseases, the expansion of telemedicine and digital therapeutics, and the increasing collaborations between pharmaceutical and technology companies are also contributing to market growth. Furthermore, the development of cost-effective and user-friendly smart pill solutions, supportive regulatory frameworks, and growing investments in digital health technologies are propelling the market forward.

SCOPE OF STUDY:

The report analyzes the Smart Pills market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring); End-Use (Hospital, Diagnostic Center, Research Institute); Target Area (Esophagus, Small Intestine, Large Intestine, Stomach)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Smart Pills - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Focus on Remote Patient Monitoring and Healthcare Automation Drives Market Growth
    • Advancements in Sensor Technologies and Miniaturization Propel Smart Pills Market Expansion
    • Rising Demand for Personalized Medicine Strengthens Business Case for Smart Pills
    • Growth in Geriatric Population and Chronic Disease Management Spurs Adoption
    • Development of Smart Pills with Real-Time Data Transmission and Feedback Enhances Market Competitiveness
    • Integration with AI and Big Data Analytics in Healthcare Expands Addressable Market Opportunity
    • Emergence of Smart Pills with Ingestible Sensors for Drug Delivery and Diagnostics Generates New Opportunities
    • Rising Interest in Digital Health and Telemedicine Solutions Supports Market Growth
    • Focus on Enhancing Patient Adherence and Treatment Outcomes Propels Demand for Smart Pills
    • Growing Applications in Clinical Trials and Therapeutic Monitoring Accelerate Market Adoption
    • Development of User-Friendly, Patient-Centric Smart Pills Supports Market Differentiation
    • Need for Integration with Broader Digital Health Ecosystems Drives Market Evolution
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Smart Pills Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Esophagus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Esophagus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Small Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Small Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Large Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Large Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Stomach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Capsule Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Capsule Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Patient Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Patient Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Center by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Diagnostic Center by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Research Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • JAPAN
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • CHINA
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • EUROPE
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Smart Pills by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • FRANCE
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • GERMANY
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • UNITED KINGDOM
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Smart Pills Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2025 & 2030

IV. COMPETITION